Emerg Infect Dis. 2009 Oct;15(10):1556-61.

Nontuberculous mycobacteria infections and anti-tumor necrosis factor-alpha therapy.

Winthrop KL, Chang E, Yamashita S, Iademarco MF, LoBue PA.

Source

Departments of Infectious Diseases, Ophthalmology, and Public Health and Preventive Medicine, Oregon Health and Sciences University, Portland, Oregon 97239, USA. winthrop@ohsu.edu

Abstract

Patients receiving anti-tumor necrosis factor-alpha (anti-TNF-alpha) therapy are at increased risk for tuberculosis and other granulomatous diseases, but little is known about illness caused by nontuberculous mycobacteria (NTM) in this setting. We reviewed the US Food and Drug Administration MedWatch database for reports of NTM disease in patients receiving anti-TNF-alpha therapy. Of 239 reports collected, 105 (44%) met NTM disease criteria. Median age was 62 years; the majority of patients (66, 65%) were female, and most (73, 70%) had rheumatoid arthritis. NTM infections were associated with infliximab (n = 73), etanercept (n = 25), and adalimumab (n = 7); most patients were taking prednisone (n = 68, 65%) or methotrexate (n = 58, 55%) concurrently. Mycobacteria avium (n = 52, 50%) was most commonly implicated, and 9 patients (9%) had died at the time their infections were reported. A high rate of extrapulmonary manifestations (n = 46, 44%) was also reported.

PMID:: 19861045; [PubMed - indexed for MEDLINE]
PMCID:: PMC2866401

Free PMC Article

Images from this publication.See all images (2) Free text

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

1K08HS017552-01/HS/AHRQ HHS/United States

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Mycobacterial Infections - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

The reliability of diagnostic coding and laboratory data to identify tuberculosis and nontuberculous mycobacterial disease among rheumatoid arthritis patients using anti-tumor necrosis factor therapy. [Pharmacoepidemiol Drug Saf. 2011]
The reliability of diagnostic coding and laboratory data to identify tuberculosis and nontuberculous mycobacterial disease among rheumatoid arthritis patients using anti-tumor necrosis factor therapy.
Winthrop KL, Baxter R, Liu L, McFarland B, Austin D, Varley C, Radcliffe L, Suhler E, Choi D, Herrinton LJ. Pharmacoepidemiol Drug Saf. 2011 Mar; 20(3):229-35. Epub 2010 Dec 10.
Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry. [Arthritis Rheum. 2009]
Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry.
Tubach F, Salmon D, Ravaud P, Allanore Y, Goupille P, Bréban M, Pallot-Prades B, Pouplin S, Sacchi A, Chichemanian RM, et al. Arthritis Rheum. 2009 Jul; 60(7):1884-94.
Review Mycobacterium abscessus infection after use of tumor necrosis factor alpha inhibitor therapy: case report and review of infectious complications associated with tumor necrosis factor alpha inhibitor use. [Diagn Microbiol Infect Dis. 2005]
Review Mycobacterium abscessus infection after use of tumor necrosis factor alpha inhibitor therapy: case report and review of infectious complications associated with tumor necrosis factor alpha inhibitor use.
Mufti AH, Toye BW, Mckendry RR, Angel JB. Diagn Microbiol Infect Dis. 2005 Nov; 53(3):233-8. Epub 2005 Oct 24.
Adalimumab in the therapy of uveitis in childhood. [Br J Ophthalmol. 2007]
Adalimumab in the therapy of uveitis in childhood.
Biester S, Deuter C, Michels H, Haefner R, Kuemmerle-Deschner J, Doycheva D, Zierhut M. Br J Ophthalmol. 2007 Mar; 91(3):319-24. Epub 2006 Oct 11.
Review A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness. [Health Technol Assess. 2006]
Review A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.
Chen YF, Jobanputra P, Barton P, Jowett S, Bryan S, Clark W, Fry-Smith A, Burls A. Health Technol Assess. 2006 Nov; 10(42):iii-iv, xi-xiii, 1-229.

See reviews... See all...

Cited by 2 PubMed Central articles

Choice of Biologic Therapy for Patients with Rheumatoid Arthritis: The Infection Perspective. [Curr Rheumatol Rev. 2011]
Choice of Biologic Therapy for Patients with Rheumatoid Arthritis: The Infection Perspective.
Keyser FD. Curr Rheumatol Rev. 2011 Feb; 7(1):77-87.
Atypical mycobacterial infection presenting as persistent skin lesion in a patient with ulcerative colitis. [Case Report Med. 2011]
Atypical mycobacterial infection presenting as persistent skin lesion in a patient with ulcerative colitis.
Bamias G, Daikos GL, Siakavellas SI, Kaltsa G, Smilakou S, Katsogridakis I, Vafiadis-Zouboulis I, Ladas SD. Case Report Med. 2011; 2011:480987. Epub 2011 Oct 5.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Nontuberculous mycobacteria infections and anti-tumor necrosis factor-alpha ther...
Nontuberculous mycobacteria infections and anti-tumor necrosis factor-alpha therapy.
Emerg Infect Dis. 2009 Oct ;15(10):1556-61.

PubMed
Diagnostic safety-netting.
Diagnostic safety-netting.
Br J Gen Pract. 2009 Nov ;59(568):872-4; discussion 874.

PubMed
Gleason score and laterality concordance between prostate biopsy and prostatecto...
Gleason score and laterality concordance between prostate biopsy and prostatectomy specimens.
Int Braz J Urol. 2009 Sep-Oct ;35(5):559-64.

PubMed
Developing capacity in health informatics in a resource poor setting: lessons fr...
Developing capacity in health informatics in a resource poor setting: lessons from Peru.
Hum Resour Health. 2009 Oct 27 ;7:80.

PubMed
High resolution carotid black-blood 3T MR with parallel imaging and dedicated 4-...
High resolution carotid black-blood 3T MR with parallel imaging and dedicated 4-channel surface coils.
J Cardiovasc Magn Reson. 2009 Oct 27 ;11:41.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: